Mickleborough, T. D., Vaughn, C. L., Shei, R.-J, Davis, E. M. & Wilhite, D. P. (2013). Marine lipid fraction PCSO-524™ (lyprinol®/omega XL®) of the New Zealand green lipped mussel attenuates hyperpnea-induced bronchoconstriction in asthma. Respiratory Medicine doi: 10.1016/j.rmed.2013.04.010
APA-Zitierstil (7. Ausg.)Mickleborough, T. D., Vaughn, C. L., Shei, R., Davis, E. M., & Wilhite, D. P. (2013). Marine lipid fraction PCSO-524™ (lyprinol®/omega XL®) of the New Zealand green lipped mussel attenuates hyperpnea-induced bronchoconstriction in asthma. Respiratory Medicine.
Chicago-Zitierstil (17. Ausg.)Mickleborough, T. D., C. L. Vaughn, R.-J Shei, E. M. Davis, und D. P. Wilhite. "Marine Lipid Fraction PCSO-524™ (lyprinol®/omega XL®) of the New Zealand Green Lipped Mussel Attenuates Hyperpnea-induced Bronchoconstriction in Asthma." Respiratory Medicine 2013.
MLA-Zitierstil (9. Ausg.)Mickleborough, T. D., et al. "Marine Lipid Fraction PCSO-524™ (lyprinol®/omega XL®) of the New Zealand Green Lipped Mussel Attenuates Hyperpnea-induced Bronchoconstriction in Asthma." Respiratory Medicine, 2013.